Ketamine Recruiting Phase 3 Trials for Treatment Resistant Depression (TRD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03742557Evaluation of Schemes of Administration of Intravenous Ketamine in Depression